Caixin
Company Index
Gilead
Gilead
NEWS
company-info
It plans to charge $390 a vial, or $2,340 for a five-day regimen, for direct government purchases by the U.S. or other developed countries
Jun.30 2020 15:14 PM
company-info
Five companies will be allowed to supply remdesivir to 127 mostly low- and middle-income countries
May.14 2020 20:45 PM
company-info
WHO warns of pandemic disaster in Africa and sees coronavirus as permanent; Jia Yueting’s Leshi finally being delisted; China gives consumers $2.7 billion
May.14 2020 20:38 PM
company-info
The rapid move by Japan’s usually conservative authorities comes days after the U.S. authorized the drug for emergency use on virus patients
May.8 2020 14:23 PM
company-info
Tourists hit the road in China for the Labor Day holiday after months of being cooped up; Shenyang expands virus testing; PBOC chief sees GDP rebounding
May.4 2020 19:39 PM
company-info
Research published this week shows remdesivir might be effective, or might not, though each of the three studies has its faults
Apr.30 2020 21:37 PM
company-info
Russia’s prime minister steps down with coronavirus; China clears pilot test of REITs to spur economy; BOC told to probe failed crude oil investment product
Apr.30 2020 21:32 PM
company-info
Positive results on Gilead’s Covid-19 drug cheer Wall Street; Chinese trying to get back from Russia face a high hurdle; Luckin delays annual financial report
Apr.29 2020 21:07 PM
company-info
Data posted accidentally to WHO website shows remdesivir didn’t improve patients’ condition in rigorous Chinese trials, which have since been discontinued
Apr.24 2020 21:12 PM
company-info
Report suggesting drug may work on Covid-19 lifts overall U.S. market though Gilead says findings aren’t complete; China confirms tests of central bank’s digital yuan
Apr.19 2020 11:16 AM
company-info
Lack of enough patients forces end of test of remdesivir for mild cases after trial in severe patients was halted Friday
Apr.17 2020 04:12 AM
company-info
Two-thirds of 53 patients treated with remdesivir improved, new study shows, but lead author cautions against definitive conclusions
Apr.11 2020 14:06 PM
company-info
Patients treated using AbbVie’s Kaletra died at a similar rate to those who only had standard care, peer-reviewed research shows
Mar.19 2020 21:02 PM
company-info
Wuhan Research Institute says it will withdraw its competing patent claim if Gilead pledges to work with China to fight coronavirus
Feb.27 2020 06:30 AM
company-info
Although remdesivir so far appears to be more effective at fighting the deadly virus than other antivirals, the evidence remains light
Feb.7 2020 20:29 PM
company-info
Move by Wuhan Institute of Virology would clear the way for clinical trials while balancing need to fight virus with China’s commitments to protect intellectual property
Feb.6 2020 03:35 AM
company-info
The aging population and a raft of lifestyle factors mean that more new cancer patients are emerging in China than anywhere else
Dec.11 2019 15:15 PM
company-info
Six other biotech companies file for listings on city’s exchange
Jul.20 2018 23:42 PM
company-info
American drugmaker to sell Solvaldi for one-fifth of its price in the U.S.
Nov.28 2017 18:34 PM